论文部分内容阅读
目的观察绝经后骨质疏松患者以中药骨舒康用药治疗的效果,旨在为临床治疗工作提供有效参考。方法选取医院科室收治的患绝经后骨质疏松症患者100例,参考随机双盲分组法分为对照组和观察组,每组50例。对照组确诊后行常规西医治疗,观察组确诊后接受与对照组相同的治疗,同时以中药骨舒康联合用药治疗。治疗完毕后比较2组的临床疗效,观察2组患者治疗前、后的髋部骨密度与血清ALP水平变化情况。结果观察组治疗总有效率为74.00%,显著高于对照组的32.00%(P<0.01)。治疗后,对照组髋部骨密度与血清ALP水平与治疗前比较差异无统计学意义(P>0.05);观察组治疗后髋部骨密度、血清ALP水平与治疗前、对照组治疗后比较差异有统计学意义(P<0.05)。结论针对绝经后骨质疏松患者以中药骨舒康用药治疗效果显著,值得借鉴推广。
Objective To observe the effect of Guoshukang on postmenopausal osteoporosis patients, and to provide an effective reference for clinical treatment. Methods A total of 100 patients with postmenopausal osteoporosis admitted to the hospital department were enrolled in this study. They were divided into control group and observation group by randomized double-blind grouping method, 50 cases in each group. The control group after the diagnosis of conventional Western medicine treatment, the observation group after receiving the same treatment with the control group, while the traditional Chinese medicine Gushukang combined treatment. After treatment, the clinical efficacy of two groups were compared. The changes of hip BMD and serum ALP level before and after treatment were observed in two groups. Results The total effective rate of the observation group was 74.00%, which was significantly higher than that of the control group (32.00%, P <0.01). After treatment, there was no significant difference in the hip BMD and serum ALP between the control group and before treatment (P> 0.05). The BMD and serum ALP level in the control group were significantly lower than those before treatment There was statistical significance (P <0.05). Conclusion For patients with postmenopausal osteoporosis with traditional Chinese medicine Shugan Kang significant effect, it is worth learning from.